{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:19Z","timestamp":1753890919935,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is the second most common kind of autoimmune encephalitis following anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. Anti-LGI1 encephalitis is characterized by cognitive impairment or rapid progressive dementia, psychiatric disorders, epileptic seizures, faciobrachial dystonic seizures (FBDS), and refractory hyponatremia. Recently, we found an atypical manifestation of anti-LGI1 encephalitis, in which paroxysmal limb weakness was the initial symptom. In this report, we describe five cases of anti-LGI1 encephalitis with paroxysmal limb weakness. Patients had similar presentations, where a sudden weakness involving a unilateral limb was observed, which lasted several seconds and occurred dozens of times each day, with the anti-LGI1 antibody being positive in both serum and cerebrospinal fluid (CSF). FBDS occurred after a mean of 12 days following paroxysmal limb weakness in three of five patients (Cases 1, 4, and 5). All patients were given high-dose steroid therapy, which had a good effect on their condition. Based on this report, we suggest that paroxysmal unilateral weakness may be a kind of epilepsy and be connected to FBDS. As an unusual neurological presentation, paroxysmal weakness can be included in the clinical manifestations of anti-LGI1 encephalitis, helping to raise awareness of the recognition of anti-LGI1 encephalitis in patients with this symptom and leading to early diagnosis and early treatment, which would contribute to improved clinical outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1191823","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T04:47:02Z","timestamp":1684990022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases"],"prefix":"10.3389","volume":"14","author":[{"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baizhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingbin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.180514","article-title":"Autoimmune encephalitis: an expanding frontier of neuroimmunology","volume":"129","author":"Guan","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577598","article-title":"Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics","volume":"357","author":"Zuliani","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.803752","article-title":": clinical features and early recognition of 242 cases of autoimmune encephalitis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.986853","article-title":"Case report: paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.181548","article-title":"Diagnosing autoimmune limbic encephalitis","volume":"191","author":"Budhram","year":"2019","journal-title":"CMAJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl421","article-title":"The epilepsy geneLGI1 encodes a secreted glycoprotein that binds to the cell surface","volume":"15","author":"Sirerol-Piquer","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914537107","article-title":"Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy","volume":"107","author":"Fukata","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy253","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-6946-7","article-title":"Faciobrachial dystonic sezures arise from cortico-subcortical abnormal brain areas","volume":"260","author":"Boesebeck","year":"2013","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.08.019","article-title":"Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis","volume":"88","author":"Li","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1517\/14656566.2010.513971","article-title":"Treatment of paroxysmal dyskinesias","volume":"12","author":"Strzelczyk","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2017.0936","article-title":"Seizure semiology of anti-LGI1 antibody encephalitis","volume":"19","author":"Beimer","year":"2017","journal-title":"Epileptic Disord"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5607\/en.2013.22.4.337","article-title":"Anti-LGI1 limbic encephalitis presented with atypical manifestations","volume":"22","author":"Lee","year":"2013","journal-title":"Exp Neurobiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1191823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T04:47:05Z","timestamp":1684990025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1191823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2023.1191823"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1191823","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"article-number":"1191823"}}